The Role of the Human Virome in Heart, Lung, and Blood Health and Resilience (R61/R33)

Funding Agency:
National Institutes of Health

The human virome includes viruses that infect host cells, virus-derived elements in our chromosomes, and viruses that infect other types of organisms that inhabit the human body. The virome may influence the host in profound ways independent of classical viral diseases. The purpose of this Funding Opportunity Announcement (FOA) is to support research to identify and evaluate the basic underlying molecular and physiological mechanisms by which the virome may influence heart, lung, and blood (HLB) health and resilience.    


  • Letter of Intent Due Date(s): May 24, 2016
  • Application Due Date(s): June 24, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
  • AIDS Application Due Date(s): August 9, 2016 by 5:00 PM local time of applicant organization. 

​RFA-HL-17-002 Expiration Date August 10, 2016

Agency Website

Amount Description

Application budgets may not exceed direct costs of $170,000 in FY2017, $170,000 in FY2018, $485,000 in FY2019, $485,000 in FY2020, and $485,000 in FY2021.

The project period is limited to up to 2 years for phase I (R61) and up to 3 years for phase II (R33) for a total project period of up to 5 years.

Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science

External Deadline

June 24, 2016